Intratumour heterogeneity in urologic cancers: From molecular evidence to clinical implications

Gerlinger, M, Catto, J.W., Orntoft, T.F. et al. (3 more authors) (2014) Intratumour heterogeneity in urologic cancers: From molecular evidence to clinical implications. European Urology, 67 (4). 729 - 737. ISSN 0302-2838

Abstract

Metadata

Authors/Creators:
  • Gerlinger, M
  • Catto, J.W.
  • Orntoft, T.F.
  • Real, F.X.
  • Zwarthoff, E.C.
  • Swanton, C.
Copyright, Publisher and Additional Information: © 2014 Elsevier. This is an author produced version of a paper subsequently published in European Urology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: Biomarker; Bladder cancer; Cancer evolution; Genetics; Personalised medicine; Prostate cancer; Renal cancer; Tumour heterogeneity
Dates:
  • Published: 21 April 2014
  • Accepted: 2 May 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 05 Nov 2015 17:44
Last Modified: 05 Nov 2015 17:51
Published Version: http://dx.doi.org/10.1016/j.eururo.2014.04.014
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.eururo.2014.04.014

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics